UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Migraine Headache and Patent Foramen Ovale

Cardiology clinics, 2024-11, Vol.42 (4), p.497-507

2024

Volltextzugriff (PDF)

Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention

Journal of the American College of Cardiology, 2024-01, Vol.83 (1), p.17-31

2024

Volltextzugriff (PDF)

Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54

European heart journal, 2016-04, Vol.37 (14), p.1133-1142

2016

Volltextzugriff (PDF)

Spoiled for Choice: P2Y12 Receptor Inhibition in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

JACC. Cardiovascular interventions, 2024-06, Vol.17 (11), p.1371-1373

2024

Volltextzugriff (PDF)

Oral Antiplatelet Therapy Administered Upstream to Patients With NSTEMI

Critical pathways in cardiology, 2020-12, Vol.19 (4), p.166-172

2020

Volltextzugriff (PDF)

Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54

Journal of the American College of Cardiology, 2017-09, Vol.70 (11), p.1368-1375

2017

Volltextzugriff (PDF)

P2Y12 inhibition in acute coronary syndromes treated with percutaneous intervention – Understanding the debate on Prasugrel or Ticagrelor

Pharmacology & therapeutics (Oxford), 2022-05, Vol.233, p.108029-108029, Article 108029

2022

Volltextzugriff (PDF)

Migraine Headache and Patent Foramen Ovale: Observational Studies, the Randomized Clinical Trials, and the GORE RELIEF Clinical Study

Cardiology clinics, 2024-11, Vol.42 (4), p.497

2024

Volltextzugriff (PDF)

Preprocedural P2Y12 inhibition and decrease in platelet count following transcatheter aortic valve replacement

Catheterization and cardiovascular interventions, 2019-11, Vol.94 (6), p.812-817

2019

Volltextzugriff (PDF)

Comparative Safety and Effectiveness of Loading Doses of P2Y12 Inhibitors in Patients Undergoing Elective PCI: a Network Meta-analysis

Cardiovascular drugs and therapy, 2023-04, Vol.37 (2), p.291-298

2023

Volltextzugriff (PDF)

Safety and Cumulative Incidence of Major Cardiovascular Events with Ticagrelor in Taiwanese Patients with Non-ST-Segment Elevation Myocardial Infarction: A 12-Month, Prospective, Phase IV, Multicenter, Single-Arm Study

Acta Cardiologica Sinica, 2020-05, Vol.36 (3), p.195-206

2020

Volltextzugriff (PDF)

Antithrombotic Strategy for Patients with Acute Coronary Syndrome: A Perspective from East Asia

Journal of clinical medicine, 2020-06, Vol.9 (6), p.1963

2020

Volltextzugriff (PDF)

P2Y12 Inhibition in Murine Myocarditis Results in Reduced Platelet Infiltration and Preserved Ejection Fraction

Cells (Basel, Switzerland), 2021-12, Vol.10 (12), p.3414

2021

Volltextzugriff (PDF)

Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective

Journal of clinical medicine, 2020-07, Vol.9 (7), p.2064

2020

Volltextzugriff (PDF)

Platelet aggregation in response to ADP is highly variable in normal donors and patients on anti-platelet medication

Clinical chemistry and laboratory medicine, 2016-07, Vol.54 (7), p.1269-1273

2016

Volltextzugriff (PDF)

Comparison of a new ELISA‐based with the flow cytometric assay for vasodilator‐associated stimulated phosphoprotein phosphorylation to assess P2Y12‐inhibition after ticagrelor intake

Cytometry. Part B, Clinical cytometry, 2015-11, Vol.88 (6), p.385-388

2015

Volltextzugriff (PDF)

Current status of data on cangrelor

Pharmacology & therapeutics (Oxford), 2016-03, Vol.159, p.102-109

2016

Volltextzugriff (PDF)

Cangrelor - Expanding therapeutic options in patients with acute coronary syndrome

Cardiology journal, 2024-01, Vol.31 (1), p.133-146

2024

Volltextzugriff (PDF)

Low incidence of hemorrhagic complications both during and after surgical procedures in patients maintained on prasugrel single antiplatelet therapy

Journal of neuroradiology, 2023-02, Vol.50 (1), p.65-73

2023

Volltextzugriff (PDF)

Prasugrel: A New Antiplatelet Drug for the Prevention and Treatment of Cardiovascular Disease

Cardiology in review, 2008-11, Vol.16 (6), p.314-318

2008

Volltextzugriff (PDF)

Thienopyridines and other ADP-receptor antagonists

Handbook of experimental pharmacology, 2012 (210), p.165

2012

Volltextzugriff (PDF)

Management of aspirin intolerance in patients undergoing percutaneous coronary intervention. The role of mono-antiplatelet therapy: a retrospective, multicenter, study

Minerva cardioangiologica, 2019-04, Vol.67 (2), p.94

2019

Volltextzugriff (PDF)

Optimizing Platelet P2Y12 Inhibition for Patients Undergoing PCI

Cardiovascular drug reviews, 2007, Vol.25 (2), p.188-203

2007

Volltextzugriff (PDF)

Cangrelor

Pharmacology in the Catheterization Laboratory, 2009, p.53-58

2009

Volltextzugriff (PDF)

Antiplatelet activity of astaxanthin in control- and high cholesterol-fed rats mediated by down-regulation of P2Y12, inhibition of NF-κB, and increasing intracellular levels of cAMP

Platelets (Edinburgh), 2021-05, Vol.32 (4), p.469-478

2021

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(54)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Humans
(40)
Life Sciences & Biomedicine
(39)
Cardiovascular System & Cardiology
(23)
Male
(19)
Female
(18)
Inhibition
(17)
Platelet Inhibition
(17)
Cardiac & Cardiovascular Systems
(16)
Clopidogrel
(16)
P2y12 Inhibition
(16)
P2y
(15)
Platelet Aggregation - Drug Effects
(15)
Ticlopidine - Analogs & Derivatives
(15)
Percutaneous Coronary Intervention
(14)
Platelet Aggregation Inhibitors - Pharmacology
(14)
Middle Aged
(13)
Platelet Aggregation Inhibitors - Adverse Effects
(13)
Prasugrel
(13)
Cangrelor
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Migraine Headache and Patent Foramen Ovale

Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention

Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54

Spoiled for Choice: P2Y12 Receptor Inhibition in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Oral Antiplatelet Therapy Administered Upstream to Patients With NSTEMI

Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54

P2Y12 inhibition in acute coronary syndromes treated with percutaneous intervention – Understanding the debate on Prasugrel or Ticagrelor

Migraine Headache and Patent Foramen Ovale: Observational Studies, the Randomized Clinical Trials, and the GORE RELIEF Clinical Study

Preprocedural P2Y12 inhibition and decrease in platelet count following transcatheter aortic valve replacement

Comparative Safety and Effectiveness of Loading Doses of P2Y12 Inhibitors in Patients Undergoing Elective PCI: a Network Meta-analysis

Safety and Cumulative Incidence of Major Cardiovascular Events with Ticagrelor in Taiwanese Patients with Non-ST-Segment Elevation Myocardial Infarction: A 12-Month, Prospective, Phase IV, Multicenter, Single-Arm Study

Antithrombotic Strategy for Patients with Acute Coronary Syndrome: A Perspective from East Asia

P2Y12 Inhibition in Murine Myocarditis Results in Reduced Platelet Infiltration and Preserved Ejection Fraction

Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective

Platelet aggregation in response to ADP is highly variable in normal donors and patients on anti-platelet medication

Comparison of a new ELISA‐based with the flow cytometric assay for vasodilator‐associated stimulated phosphoprotein phosphorylation to assess P2Y12‐inhibition after ticagrelor intake

Current status of data on cangrelor

Cangrelor - Expanding therapeutic options in patients with acute coronary syndrome

Low incidence of hemorrhagic complications both during and after surgical procedures in patients maintained on prasugrel single antiplatelet therapy

Prasugrel: A New Antiplatelet Drug for the Prevention and Treatment of Cardiovascular Disease

Thienopyridines and other ADP-receptor antagonists

Management of aspirin intolerance in patients undergoing percutaneous coronary intervention. The role of mono-antiplatelet therapy: a retrospective, multicenter, study

Optimizing Platelet P2Y12 Inhibition for Patients Undergoing PCI

Cangrelor

Antiplatelet activity of astaxanthin in control- and high cholesterol-fed rats mediated by down-regulation of P2Y12, inhibition of NF-κB, and increasing intracellular levels of cAMP

Suchergebnisse filtern